Product Information

ATOVAQUONE-PROGUANIL 250-100 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.4777 per EA under NDC 00378416201. Its NADAC has been published 632 times since Jul 16, 2014.

FDA first approved this application on May 27, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the atovaquone and proguanil hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for ATOVAQUONE-PROGUANIL 250-100 MG TABLET has been published 632 times since Jul 16, 2014, and over the history we have for it it has declined 72.1%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.